Interestingly, CCT3 expression was found to be upregulated in patients with lipid metabolism disorders (metabolic‐associated fatty liver disease and nonalcoholic steatohepatitis), as determined via analysis of publicly available data.149. Here, CCT3 is linked to fatty liver disease.